Status:
COMPLETED
The Effect of Human Placental Explants and Pregnant Women Sera on Cancer Cells
Lead Sponsor:
Meir Medical Center
Conditions:
Cancer
Eligibility:
FEMALE
18-45 years
Brief Summary
Maternal malignancy during pregnancy is estimated to occur in 1 out of 1000 pregnancies. Controversy exists regarding the effect of pregnancy on cancer prognosis. Gestational hormones and pregnancy-re...
Detailed Description
In the Oncogenetic laboratory cancer cells will be exposed to first trimester human placental explants or to serum collected from pregnant women. As a control cancer cells will be cultured alone or in...
Eligibility Criteria
Inclusion
- Healthy women
- Age 18-45.
- Pregnant (6-9 weeks) and non pregnant women.
Exclusion
- • Placentae that were destroyed during pregnancy termination.
Key Trial Info
Start Date :
November 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01879436
Start Date
November 1 2013
End Date
July 1 2019
Last Update
November 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oncogenetic Laboratory, Meir Medical Center
Kfar Saba, Israel